In particular, BAX mRNA was diminished in advanced-stage (T3 and T4) nasopharyngeal tumors and/or metastatic tumors, accompanied either by a number of positive regional lymph nodes only, or also by infiltration of distal organs. The gene discussed is BAX; the disease is metastatic neoplasm.